Clinical Trials Directory

Trials / Completed

CompletedNCT01496261

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial

Comparative Pharmacokinetics of Clopidogrel 75mg and Aspirin 100mg After Single Oral Administration as a Fixed Dose Combination Versus Separate Combination in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Chong Kun Dang Pharmaceutical · Industry
Sex
Male
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare pharmacokinetics between fixed-dose combination and separate combination of clopidogrel 75mg/aspirin 100mg.

Conditions

Interventions

TypeNameDescription
DRUGClopidogrel and AspirinClopidogrel and Aspirin seperate combination, single dose
DRUGFixed dose combination of clopidogrel/aspirinFixed dose combination of clopidogrel/aspirin

Timeline

Start date
2011-08-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2011-12-21
Last updated
2011-12-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01496261. Inclusion in this directory is not an endorsement.